Literature DB >> 31933285

Genome Editing: Promoting Responsible Research.

François Hirsch1,2, Christine Lemaitre3,4, Hervé Chneiweiss3,5,4,6,7,8, Lluis Montoliu9,10,11.   

Abstract

For more than 40 years, scientists have been developing tools and technologies for genome modification; however, initial progress was slow and few outside of the molecular biology community took an interest in the field. Everything has dramatically changed with the recent appearance of the so-called precision approaches, and especially with the 'CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) revolution'. With great powers come great responsibilities. CRISPR-derived technologies have been proven efficient, cheap, rather easy and fast, and provided universal access to genome modification techniques beyond the leading research centers and reference laboratories. The popularization of techniques to manipulate the human genome and that of all other living beings consequently raises many essential questions, on the ethical and legal sides, both for the scientific community and the lay public. In order to mitigate excessive hype and concern among citizens, a call for the mobilization of the various stakeholders is now urgent through a global governance of genome editing.

Entities:  

Mesh:

Year:  2019        PMID: 31933285     DOI: 10.1007/s40290-019-00276-1

Source DB:  PubMed          Journal:  Pharmaceut Med        ISSN: 1178-2595


  28 in total

1.  Correction of a pathogenic gene mutation in human embryos.

Authors:  Hong Ma; Nuria Marti-Gutierrez; Sang-Wook Park; Jun Wu; Yeonmi Lee; Keiichiro Suzuki; Amy Koski; Dongmei Ji; Tomonari Hayama; Riffat Ahmed; Hayley Darby; Crystal Van Dyken; Ying Li; Eunju Kang; A-Reum Park; Daesik Kim; Sang-Tae Kim; Jianhui Gong; Ying Gu; Xun Xu; David Battaglia; Sacha A Krieg; David M Lee; Diana H Wu; Don P Wolf; Stephen B Heitner; Juan Carlos Izpisua Belmonte; Paula Amato; Jin-Soo Kim; Sanjiv Kaul; Shoukhrat Mitalipov
Journal:  Nature       Date:  2017-08-02       Impact factor: 49.962

2.  As CRISPR-Cas adoption soars, summit calls for genome editing oversight.

Authors:  Eric Smalley
Journal:  Nat Biotechnol       Date:  2018-06-06       Impact factor: 54.908

Review 3.  On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.

Authors:  Francisco J M Mojica; Lluis Montoliu
Journal:  Trends Microbiol       Date:  2016-07-09       Impact factor: 17.079

4.  CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.

Authors:  Su Yang; Renbao Chang; Huiming Yang; Ting Zhao; Yan Hong; Ha Eun Kong; Xiaobo Sun; Zhaohui Qin; Peng Jin; Shihua Li; Xiao-Jiang Li
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

5.  Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially modified PstI sites.

Authors:  F J Mojica; G Juez; F Rodríguez-Valera
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

6.  Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9.

Authors:  Dong Niu; Hong-Jiang Wei; Lin Lin; Haydy George; Tao Wang; I-Hsiu Lee; Hong-Ye Zhao; Yong Wang; Yinan Kan; Ellen Shrock; Emal Lesha; Gang Wang; Yonglun Luo; Yubo Qing; Deling Jiao; Heng Zhao; Xiaoyang Zhou; Shouqi Wang; Hong Wei; Marc Güell; George M Church; Luhan Yang
Journal:  Science       Date:  2017-08-10       Impact factor: 47.728

7.  Capture of authentic embryonic stem cells from rat blastocysts.

Authors:  Mia Buehr; Stephen Meek; Kate Blair; Jian Yang; Janice Ure; Jose Silva; Renee McLay; John Hall; Qi-Long Ying; Austin Smith
Journal:  Cell       Date:  2008-12-26       Impact factor: 41.582

8.  Gene targeting in embryonic stem cells scores a knockout in Stockholm.

Authors:  Tak Wah Mak
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

9.  Gene Editing in Humans: Towards a Global and Inclusive Debate for Responsible Research.

Authors:  Itziar de Lecuona; María Casado; Gemma Marfany; Manuel Lopez Baroni; Mar Escarrabill
Journal:  Yale J Biol Med       Date:  2017-12-19

10.  A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.

Authors:  Andrew Hammond; Roberto Galizi; Kyros Kyrou; Alekos Simoni; Carla Siniscalchi; Dimitris Katsanos; Matthew Gribble; Dean Baker; Eric Marois; Steven Russell; Austin Burt; Nikolai Windbichler; Andrea Crisanti; Tony Nolan
Journal:  Nat Biotechnol       Date:  2015-12-07       Impact factor: 54.908

View more
  1 in total

Review 1.  Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine.

Authors:  Matthew W McCarthy
Journal:  Expert Rev Anti Infect Ther       Date:  2020-05-04       Impact factor: 5.091

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.